Krystyna Kiel, MD

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer.
   Refaat T, Choi M, Gaber G, Kiel K, Mehta M, Gradishar W, Small W Jr.
   Am J Clin Oncol. 2013
   2013 Feb 5. [Epub ahead of print]
   
2. International Conference on Advances in Radiation Oncology (ICARO): Outcomes of an IAEA Meeting
   Salminen EK, Kiel K, Ibbott GS, Joiner MC, Rosenblatt E, Zubizarreta E, Wondergem J, Meghzifene A
   Radiat Oncol
   2011 Feb 4
   6(1):11
   
3. Change in creatinine clearance over time following upper abdominal irradiation: a dose-volume histogram multivariate analysis
   Diavolitsis VM, Rademaker A, Boyle J, Kang Z, Kiel K, Mulcahy M, Small W Jr
   Am J Clin Oncol
   2011 Feb
   34(1):53-7
   
4. Residual disease after neoadjuvant chemotherapy for breast cancer
   Morris GJ, Robinson PA, Lo S, Samuel TA, Sheikh AA, Jordan WE 3rd, Thomas LC, Kiel K, Peters CA
   Semin Oncol
   2010 Feb
   37(1):1-10
   
5. NCCN Clinical Practice Guidelines in Oncology: rectal cancer
   Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C; National Comprehensive Cancer Network
   J Natl Compr Canc Netw
   2009 Sep
   7(8):838-81
   
6. NCCN Clinical Practice Guidelines in Oncology: colon cancer
   Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C; National Comprehensive Cancer Network
   J Natl Compr Canc Netw
   2009 Sep
   7(8):778-831
   
7. Ensuring optimal interdisciplinary breast care in the United States
   Anderson BO, Carlson RW, Kaufman CS, Kiel KD
   Breast J
   2009 Nov-Dec
   15(6):569-70
   
8. Breast cancer. Clinical practice guidelines in oncology
   Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC; NCCN Breast Cancer Clinical Practice Guidelines Panel
   J Natl Compr Canc Netw
   2009 Feb
   7(2):122-92
   
9. Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer
   Hazard HW, Gorla SR, Scholtens D, Kiel K, Gradishar WJ, Khan SA
   Cancer
   2008 Oct 15
   113(8):2011-9
   
10. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
    Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R
    J Clin Oncol
    2008 Mar 1
    26(7):1086-92
    
11. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer
    Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, McCormick BM, Hirsch A, Karkar A, Motwani SB, Tereffe W, Yu TK, Sher D, Silverstein J, Kachnic LA, Kesslering C, Freedman GM, Small W Jr
    Int J Radiat Oncol Biol Phys
    2008 Feb 1
    70(2):477-84
    

• To watch a brief video of Krystyna Kiel, MD, click the play button at the lower left corner of the video frame below.
• (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
• View Transcript

• When an individual has cancer, what they want is the best treatment with the fewest side effects that they can receive. This is a very hard time in peoples’ lives. They are faced with life/death issues. And part of my job is to make sure that they’re comfortable in whatever treatment approach they choose.

  One part of radiation therapy that I love is that we really do help people. We’re either curing them or making them feel better. And it’s very gratifying to see somebody come at three, four, five years after their treatment doing really well.